Ending curative therapy even when the family wants it

Hematology/oncology requires clinicians to have some of the most difficult conversations in all of medicine. In part 2 of our 3-part series, we tackle how to talk about ending curative therapy even when the family wants to keep going.

These conversations are hosted by Ilana Yurkiewicz, MD, the host and producer of the Clinical Correlation segment and the author of Hard Questions, a monthly column at MDedge Hematology-Oncology. She is joined by the two residents who have been behind the Blood & Cancer show notes from the beginning, Emily Bryer, DO, and Ronak Mistry, DO, both of the University of Pennsylvania, Philadelphia.

David H. Henry, MD, editor in chief of MDedge Hematology-Oncology and the host of Blood & Cancer, also joins the podcast to talk about treatment discontinuation in multiple myeloma.

Timestamps:

• This week in Hematology/Oncology: 04:00
• Conversation: 08:00

Links:

• This Week in Oncology:
  • Study finds no standard for treatment discontinuation in myeloma
• Ilana Yurkiewicz, MD:
  • Dr. Yurkiewicz is a fellow in hematology and oncology at Stanford (Calif.) University.
  • Hard Questions
• Emily Bryer, DO
• Ronak Mistry, DO

For more MDedge podcasts, go to mdedge.com/podcasts

Email the show: podcasts@mdedge.com

Interact with us on Twitter: @MDedgehemonc

David Henry on Twitter: @davidhenrymd

Ilana Yurkiewicz on Twitter: @ilanayurkiewicz